Physicians most often recommend or prescribe oral
medication for relief of acute pain. This review of the available
evidence supports the use of acetaminophen in doses up to 1,000
mg as the initial choice for mild to moderate acute pain. In some
cases, modest improvements in analgesic efficacy can be achieved
by adding or changing to a nonsteroidal anti-inflammatory drug (NSAID).
The safest NSAID is ibuprofen in doses of 400 mg. Higher doses may
offer somewhat greater analgesia but with more adverse effects.
Other NSAIDs have failed to demonstrate consistently greater efficacy
or safety than ibuprofen. Although they may be more expensive, these
alternatives may be chosen for their more convenient dosing. Cyclooxygenase-2
inhibitors provide equivalent efficacy to traditional NSAIDs but
lack a demonstrable safety advantage for the treatment of acute
pain. For more severe acute pain, the evidence supports the addition
of oral narcotic medications such as hydrocodone, morphine, or oxycodone.
Specific oral analgesics that have shown poor efficacy and side
effects include codeine, propoxyphene, and tramadol.
Cheap Generic Ultram (Tramadol) is available from this off-shore
pharmacy:
Tramadol
Approximately one half of the population reports pain or discomfort
that persists continuously or intermittently for longer than three
months. An even greater number of persons are likely to have acute
pain at any one time. (1) Unfortunately, considerable confusion
exists about the efficacy and safety of commonly used analgesics.
This review provides a survey of the best available evidence regarding
oral analgesia for acute pain, which is defined as pain associated
with new tissue injury that typically lasts less than one month,
but at times for as long as six months. (2) Acute pain generally
does not involve the long-term, daily use of analgesics.
Search Strategy
Much of the literature on oral analgesics defines the efficacy
of a specific analgesic as the proportion of patients who need
to take that analgesic to experience at least a 50 percent reduction
in pain compared with placebo. The concept of number needed to
treat (NNT) is a particularly helpful way to convey this outcome.
It refers to the number of patients who have to use the treatment
for one patient to benefit. For example, when acetaminophen is
said to have an NNT of four compared with placebo, it means that
for every four patients who take acetaminophen instead of placebo,
at least one patient will experience a 50 percent decrease in
pain. The other three patients may have a significant decrease
in pain (e.g., 40 or 30 percent), but this is not reflected in
the NNT. The lower the NNT, the greater the likelihood that a
given patient will achieve a 50 percent reduction in pain. (3)
Other measures of pain relief include average decreases on visual
analog scales and functional outcome measures. A visual analog
scale is a 100-mm line with no pain at one end and severe pain
at the other. For meaningful analgesia of acute pain, patients
must report at least a 13-mm difference between analgesic choices.
(4,5)
This review focuses on the most commonly used oral analgesics
for acute pain available in the United States: acetaminophen,
nonsteroidal anti-inflammatory drugs (NSAIDs), cyclooxygenase-2
(COX-2) inhibitors, tramadol (Ultram), and opiates.
Acetaminophen
Acetaminophen is a unique analgesic without a clearly defined
mechanism. In a meta-analysis of 40 trials involving 4,171 patients
comparing acetaminophen with placebo for postoperative pain, acetaminophen
in a dose of 1,000 mg had an NNT of 4.6 (95 percent confidence
interval [CI], 3.8 to 5.4) for at least 50 percent pain relief
versus placebo. Lower doses were less effective. (6)
Direct comparative studies between acetaminophen (1,000-mg dose)
and NSAIDs show that NSAIDs are more effective than acetaminophen
in some situations (e.g., dental and menstrual pain), but provide
equivalent analgesia in others (e.g., orthopedic surgery and tension
headache). (7,8)
Aspirin
Aspirin is an effective analgesic for acute pain, but it has
not proved more effective than equal doses of acetaminophen. It
also has a worse safety profile than acetaminophen. (9)
Traditional NSAIDs
EFFICACY
NSAIDs are excellent analgesics with no clinically important
difference in efficacy among specific drugs. (10) They are superior
to acetaminophen for some types of pain, and in many acute pain
settings they provide analgesia equal to usual starting doses
of narcotics. (11) However, unlike narcotics that lack a ceiling
dose, NSAIDs have a maximum dose above which no additional analgesia
is obtained. Higher doses of NSAIDs may be used for anti-inflammatory
effects. However, this review focuses only on doses used for analgesia.
Strong evidence supports the use of nonprescription NSAIDs for
dysmenorrhea and acute postpartum pain. In a meta-analysis (12)
of randomized controlled trials (RCTs) of analgesics for dysmenorrhea,
ibuprofen (Motrin) and naproxen (Aleve, Naprosyn) were equally
effective, and both were better than acetaminophen and aspirin.
For dysmenorrhea, acetaminophen was no better than placebo. Only
naproxen had side effects worse than those of placebo. (12) Ibuprofen
has shown similar effectiveness to a combination of acetaminophen,
codeine, and caffeine for postpartum perineal pain with fewer
side effects. (13)
SAFETY AND ADVERSE EFFECTS
Side effects may limit the use of NSAIDs. The most serious side
effects include gastrointestinal (GI) bleeding and perforation,
renal dysfunction, and platelet dysfunction. Ibuprofen provides
an excellent GI safety profile that is not significantly different
from placebo in dosages of 800 to 1,200 mg per day. (14) Higher
prescription doses of naproxen and ibuprofen are associated with
increased GI side effects similar to other prescription NSAIDs.
(15) Epidemiologic data also support the use of 400 mg of ibuprofen
first when choosing an NSAID. (16) Data from studies of subacute
and chronic pain (osteoarthritis of the hip) therapy suggest that
higher doses may provide better analgesia, but have more adverse
effects. (17) [Histamine.sub.2] blockers, misoprostol (Cytotec),
and proton pump inhibitors have been shown to reduce the risk
of duodenal ulcers with daily NSAID use. (18) Only misoprostol
(800 mg per day) has been shown to reduce the risk of other serious
upper GI injury (i.e., perforation and/or bleeding). (19,20) The
NNT with misoprostol to prevent one serious GI side effect is
264 patients. Based on a cost-effectiveness analysis, researchers
concluded that misoprostol should be used only in high-risk patients.
(21)
COX-2 Selective NSAIDs
EFFICACY
Traditional NSAIDs inhibit cyclooxygenase-1 (COX-1) and COX-2
enzymes. Most of the analgesic effects of NSAIDs have been attributed
to their COX-2 inhibition, while their undesirable side effects
have been attributed to their inhibition of COX-1 enzymes. In
recent years, three new oral prescription medications (celecoxib
[Celebrex], rofecoxib [Vioxx], and valdecoxib [Bextra]) have been
marketed in the United States; they selectively inhibit COX-2
enzymes without inhibiting COX-1 enzymes. Theoretically, these
medications could provide analgesia equal to that of traditional
NSAIDs without many of the side effects. A meta-analysis of the
oldest COX-2 inhibitor, celecoxib, showed fair to good efficacy
for postoperative pain with an NNT of 4.5 (95 percent CI, 3.3
to 7.2) compared with placebo. (22) In several RCTs, (23-26) rofecoxib
has shown good analgesic efficacy for some acute pain conditions
(e.g., joint replacement surgery, dysmenorrhea), but not for others
(e.g., tonsillectomy, prostate biopsy). Valdecoxib (20 mg and
40 rag) has been effective for acute postoperative pain of wisdom
tooth extraction with an NNT of 1.6 to 1.7. (27) Valdecoxib also
has demonstrated analgesia superior to that of placebo in postoperative
knee surgery. (28) Comparative trials have confirmed that COX-2
inhibitors are no more or less effective than NSAIDs.
SAFETY AND ADVERSE EFFECTS
1 - 2
- 3 - 4
- Next